Small Caps Stock News
All posts tagged "Galectin Therapeutics"
-
211BiotechThe Next Axcella (AXLA) Squeeze –> Bioxytran (BIXT)
Axcella Therapeutics (NASDAQ: AXLA) mesmerized investors yesterday with news of a patent to treat fatigue in Long COVID. The short squeeze setup...
-
1.6K3BiotechFeuerstein’s Flab on Northwest Bio (NWBO) Dives Stock on Meritless Claims After Nailing Primary Endpoint
Northwest Biotherapeutics (OTCMKTS: NWBO) is now a risk-off biotech trading at a significant discount; in a “sell the news” market, there are...
-
906BiotechModerna’s (MRNA) Bloated Market Cap & mRNA Vaccine Thesis Under Fire
Shares of Moderna (NASDAQ: MRNA) recently spiked over $400, giving the mRNA vaccine maker a market cap of about $200 billion, greater...
-
947BiotechCytoDyn (CYDY) Shorts Throttle Up Bashing Ahead of August Super News Cycle
Short attack timed to capitalize on consolidation and thin trading The Oregonian misquotes and twists statements taken out of context SEC case...
-
524BiotechBioxtyran (OTCMKTS: BIXT) Licenses Phase 2 Asset for COVID-19 Patients After Finding Smoking Gun Journal Article
Bioxytran Inc. (OTCMKTS: BIXT) has a development stage hypoxia drug that that was initially targeting Acute Respiratory Distress Syndrome (ARDS) an...